Effect of different antibiotic therapies on the reproductive outcomes of fresh embryo transfer for chronic endometritis: A retrospective cohort study.

Objective: To investigate the reproductive outcomes by comparing two kinds of antibiotic schemes for chronic endometritis (CE) in infertile women's fresh embryo transfer (FET) cycles and identify subgroups of patients with CE who need long‐term antibiotics treatment. Design: A retrospective cohort study. Setting: University‐based reproductive medical center. Patient(s): A total of 492 women with CD138‐positive plasmacytes per 10 high‐power fields (CD138+/10HPF). Intervention(s): Hysteroscopy was performed and endometrial biopsy samples were collected in the proliferative phase. Long‐term or short‐term antibiotics were administrated. After antibiotics treatment, patients underwent in vitro fertilization (IVF)/ intracytoplasmic sperm injection (ICSI) and received ET. Main Outcome Measure(s): Ongoing pregnancy rate, clinical pregnancy rate, clinical miscarriage rate. Result (s): There were no significant differences in pregnancy outcomes between patients with CD138+/10HPF 1–4 (low‐grade CE) who received long‐term antibiotic therapy and short‐term antibiotics groups. Among women with CD138+/10HPF ≥5 (high‐grade CE), live birth rate (48.4% vs. 14.7%, p =.001), clinical pregnancy rate (66.7% vs. 35.3%, p =.002) and ongoing pregnancy rate (59.1% vs. 20.6%, p <.001) in the long‐term arm were significantly higher than that in the short‐term arm. The clinical miscarriage rate (21.0% vs. 58.3%, p =.013) was statistically lower in the long‐term antibiotics group, but no statistical differences were found between the two groups in preterm delivery rate. Conclusion: Long‐term antibiotics treatment was a sensible choice to improve pregnancy outcomes in women with CD138+/10HPF ≥5 (high‐grade CE). The pregnancy outcomes of women with low‐grade CE only defined by histological diagnosis were not greatly improved after antibiotic therapy. Therefore, we recommended the proper diagnosis criteria were CD138+/10HPF ≥5 pathologically. [ABSTRACT FROM AUTHOR]